Steve Barclay

The hon. Gentleman is absolutely right, and that builds on the earlier intervention on public support. One of the sweet spots of this area of policy is that it is beneficial to farming—because it cuts costs on things like pesticides and increases yield—but it is also hugely beneficial to nature, in terms of climate change. It is also beneficial for the public purse, because gene editing is a way of using science, in essence, to drive productivity and nature-beneficial schemes, rather than simply spending public money. For context, I am sure the Minister will have seen the farming figures this morning. The Government borrowed £20.7 billion in June alone—the highest figure since records began, with the exception of June 2020, during peak covid. That is not an isolated figure. If we look at the previous month, the Government borrowed £17.7 billion in May. That was also the highest on record for May—again, with the exception of May 2020. So the Government are borrowing record sums, and the Department’s budget is under pressure—all the more reason not to sacrifice genuine scientific opportunities, particularly those that, as we have explored, have widespread public support. Will the Minister recognise that gene editing jointly serves the goals of food production and protecting nature, and ensure that we do not give away our competitive advantage? Specifically, will he confirm that the £12.5 million from the recent farming futures research and development fund for the precision breeding competition—aimed at mid-stage precision breeding projects—will be paid in full? Will he also confirm that funding will be made available directly to farmers to take part in field trials, so that the science actually progresses? In conclusion, gene editing is a genuine Brexit opportunity. It can boost economic growth, support food production, help protect our environment, and give us a competitive advantage over other countries. To sacrifice that as part of some UK-EU reset negotiations would be a serious mistake. It would be another example in a long list of decisions where the Department has been overridden by the Treasury. There is still time. The legislation is in place; the regulations are there. Can the Minister confirm today that gene editing will continue to be a priority, and that the UK Government will secure the advantages that it offers?